Hong Kong to trial non-invasive sound wave treatment for kidney tumours
In short
- Li Ka-shing funds places for 30 patients in the trials.
- Three private hospitals will run them: CUHK Medical Centre, Gleneagles Hospital Hong Kong and Hong Kong Sanatorium & Hospital.
- The technique, histotripsy, uses focused sound waves to break apart tumours without surgical incisions.
Why it's good news
Histotripsy aims to treat tumours without the cuts of surgery. The Li Ka Shing Foundation is paying for places in the trials, which start at three private hospitals in Hong Kong. These are early clinical trials, so the treatment's benefits and safety are still being tested.
From South China Morning Post
Hong Kong will become the first city in Asia to conduct clinical trials of a non-invasive treatment for kidney tumours, with tycoon Li Ka-shing funding places for 30 patients across three private hospitals. The Li Ka Shing Foundation announced on Wednesday that CUHK Medical Centre, Gleneagles Hospital Hong Kong and Hong Kong Sanatorium & Hospital would launch the trials using histotripsy, a technology that uses focused sound waves to break apart tumours without surgical incisions. The trials...